NEO

NeoGenomicsB

Nasdaq / Health Care Equipment & Services

At close

2026-07-21

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$16.50

+14.2% vs current

Most likely

Base case

60%

Probability

Target price

$13.50

-6.6% vs current

B-

Bear case

20%

Probability

Target price

$9.00

-37.7% vs current

AI sentiment snapshot

Latest data as of 2026-01-07

AI commentary

Street consensus price targets cluster close to the current price, suggesting muted upside in the near term [#SERP-2]. Coverage shows a range of opinions with some upside outliers but overall cautious tones driven by reimbursement and volume uncertainty [#SERP-1].

RankAlpha Sentiment AI - 2026-01-07

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-04-07catalystQ4 2025 / FY 2025 earnings releaseHigh impact

Quarterly results and guidance update that typically moves volume/testing revenue estimates; date estimated conservatively (no official date disclosed) and may drive a near-term re-rate [#SERP-2].

2026-06-30eventStrategic partnership or M&A announcement (industry consolidation)High impact

Potential partnership or acquisition discussions noted as industry theme; assumed window end of H1 2026 for conservatism (assumption noted).

2027-01-07catalystBroader adoption of NeoGenomics oncology testing panelsHigh impact

Gradual market-share gains from new panels and commercial expansion into larger reference lab customers; outcome material over ~12 months if uptake accelerates.

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-01-07 • Updated nightlySource: Internal modelMethodology